Cannabinoid-based drugs as anti-inflammatory therapeutics

Cited by (741)

Items 301–400 of 741

1. Self-reported lifetime marijuana use and interleukin-6 levels in middle-aged African Americans
   Larry Keen, Deidre Byrnes Pereira, William W. Latimer · 2014 · Drug and Alcohol Dependence
2. Exposure to Δ9-Tetrahydrocannabinol Impairs the Differentiation of Human Monocyte-derived Dendritic Cells and their Capacity for T cell Activation
   Michael D. Roth, Julie T. Castaneda, Sylvia M. Kiertscher · 2015 · Journal of Neuroimmune Pharmacology
3. Estimation of the hypothermic component in neuroprotection provided by cannabinoids following cerebral ischemia
   Peter K. Bonfils, Jakob Reith, Henrik Hasseldam, Flemming Fryd Johansen · 2006 · Neurochemistry International
4. Cannabinoid receptor CB2 protects against balloon-induced neointima formation
   Filippo Molica, Christian M. Matter, Fabienne Burger, Graziano Pelli, Sébastien Lenglet, Andreas Zimmer, Pál Pacher, Sabine Steffens · 2012 · American Journal of Physiology-Heart and Circulatory Physiology
5. Association of red cell distribution width with all-cause and cardiovascular-specific mortality in African American and white adults: a prospective cohort study
   Salman M. Tajuddin, Mike A. Nalls, Alan B. Zonderman, Michele K. Evans · 2017 · Journal of Translational Medicine
6. Modulation of Glycine Receptor Function by the Synthetic Cannabinoid HU210
   Reyhan Demir, Martin Leuwer, Jeanne de la Roche, Klaus Krampfl, Nilufar Foadi, Matthias Karst, Reinhard Dengler, Gertrud Haeseler, Jörg Ahrens · 2009 · Pharmacology
7. Virodhamine and CP55,940 modulate cAMP production and IL‐8 release in human bronchial epithelial cells
   Effimia Gkoumassi, Bart G. J. Dekkers, Melloney J. Dröge, Carolina R.S. Elzinga, Martina Schmidt, Herman Meurs, Johan Zaagsma, S. Ad Nelemans · 2007 · British Journal of Pharmacology
8. Investigating the Relationships Between Alcohol Consumption, Cannabis Use, and Circulating Cytokines: A Preliminary Analysis
   Hollis C. Karoly, L. Cinnamon Bidwell, Raeghan L. Mueller, Kent E. Hutchison · 2017 · Alcoholism Clinical and Experimental Research
9. Cannabidiol for Viral Diseases: Hype or Hope?
   Alex Mabou Tagne, Barbara Pacchetti, Mikael Hans Sodergren, Marco Cosentino, Franca Marino · 2020 · Cannabis and Cannabinoid Research
10. The Role of Cannabinoids in Allergic Diseases: Collegium Internationale Allergologicum (CIA) Update 2020
    Alba Angelina, Mario Pérez‐Diego, Jacobo López‐Abente, Óscar Palomares · 2020 · International Archives of Allergy and Immunology
11. Functional Fine-Tuning of Metabolic Pathways by the Endocannabinoid System—Implications for Health and Disease
    Estefanía Moreno, Milena R. Cavic, Enric I. Canela · 2021 · International Journal of Molecular Sciences
12. Cannabis and Inflammation in HIV: A Review of Human and Animal Studies
    Ronald J. Ellis, Natalie Wilson, Scott N. Peterson · 2021 · Viruses
13. Direct suppression of autoreactive lymphocytes in the central nervous system via the CB2 receptor
    Bonnie N. Dittel · 2007 · British Journal of Pharmacology
14. The cannabinoid receptor agonist WIN 55,212-2 reduces the initial cerebral damage after hypoxic–ischemic injury in fetal lambs
    Daniel Alonso Alconada, Francisco Jose Alvarez, Antonia A. Alvarez, Victoria Mielgo, Felipe Goñi‐de‐Cerio, Maria C. Rey-Santano, Amale Caballero, José Antonio Martínez-Orgado, Enrique Hilario · 2010 · Brain Research
15. Interactions between the Kynurenine and the Endocannabinoid System with Special Emphasis on Migraine
    Gábor Nagy-Grócz, Ferenc Zádor, Szabolcs Dvorácskó, Zsuzsanna Bohár, Sándor Benyhe, Csaba Tömböly, Árpád Párdutz, László Vécsei · 2017 · International Journal of Molecular Sciences
16. Beneficial Effects of Cannabis on Blood–Brain Barrier Function in Human Immunodeficiency Virus
    Ronald J. Ellis, Scott N. Peterson, Mariana Cherner, Erin E. Morgan, Rachel D. Schrier, Bin Tang, Martin Hoenigl, Scott Lee Letendre, Jenny Iudicello · 2020 · Clinical Infectious Diseases
17. Arylsulfonamide CB2 receptor agonists: SAR and optimization of CB2 selectivity
    Monika Ermann, Doris Riether, Edward R. H. Walker, Innocent Mushi, James E. Jenkins, Beatriz Noya-Marino, Mark L. Brewer, Malcolm G. Taylor, Patricia Amouzegh, Stephen P. East et al. · 2008 · Bioorganic & Medicinal Chemistry Letters
18. The endocannabinoid system: Body weight and metabolic regulation
    Stefan Engeli, Jens Jordan · 2006 · Clinical cornerstone
19. Cannabinoids Affect Dendritic Cell (DC) Potassium Channel Function and Modulate DC T Cell Stimulatory Capacity
    Paul W. Wacnik, Katarina M. Luhr, Russell H. Hill, Hans‐Gustaf Ljunggren, Krister Kristensson, Mattias Svensson · 2008 · The Journal of Immunology
20. Anti-neuroinflammatory Activity of a Novel Cannabinoid Derivative by Inhibiting the NF-κB Signaling Pathway in Lipopolysaccharide-Induced BV-2 Microglial Cells
    Sandeep Vasant More, Ju‐Young Park, Byung-Wook Kim, Hemant Kumar, Hyung-Woo Lim, Seong-Mook Kang, Sushruta Koppula, Sung‐Hwa Yoon, Dong‐Kug Choi · 2013 · Journal of Pharmacological Sciences
21. Potentiation of microglial endocannabinoid signaling alleviates neuroinflammation in Alzheimer's disease
    Deepthi Rapaka, Veera Raghavulu Bitra, Siva Reddy Challa, Paul Chukwuemeka Adiukwu · 2021 · Neuropeptides
22. Cannabinoid WIN55,212-2 reprograms monocytes and macrophages to inhibit LPS-induced inflammation
    Mario Pérez‐Diego, Alba Angelina, Leticia Martín‐Cruz, Andrés de la Rocha‐Muñoz, Angel E. Maldonado, Carmen Sevilla‐Ortega, Óscar Palomares · 2023 · Frontiers in Immunology
23. The role of central CB2 cannabinoid receptors on food intake in neonatal chicks
    Ladan Emadi, Hossein Jonaidi, E. Hosseini Amir Abad · 2011 · Journal of Comparative Physiology A
24. Inflammation and aging: Can endocannabinoids help?
    Yannick Marchalant, Holly M. Brothers, Gary L. Wenk · 2008 · Biomedicine & Pharmacotherapy
25. Cannabinoid Modulation of Kaposi's Sarcoma–Associated Herpesvirus Infection and Transformation
    Xuefeng Zhang, Jian Feng Wang, George Kunos, Jerome E. Groopman · 2007 · Cancer Research
26. The effects of delta-9-tetrahydrocannabinol (THC) on inflammation: A review
    Henry P. Miller, Steven C. Bonawitz, Olga Ostrovsky · 2020 · Cellular Immunology
27. Endocannabinoid System and Tumour Microenvironment: New Intertwined Connections for Anticancer Approaches
    Marta Iozzo, Giovanna Sgrignani, Giuseppina Comito, Paola Chiarugi, Elisa Giannoni · 2021 · Cells
28. Cannabidiol attenuates delayed-type hypersensitivity reactions via suppressing T-cell and macrophage reactivity
    Der-Zen Liu, Chieh-min Hu, Chung-Hsiung Huang, Shiaw‐Pyng Wey, Tong‐Rong Jan · 2010 · Acta Pharmacologica Sinica
29. Cannabis use by individuals with multiple sclerosis: effects on specific immune parameters
    Michelle Sexton, Eiron Cudaback, Rehab A. Abdullah, John S. Finnell, Laurie K. Mischley, Mary Rozga, Aron H. Lichtman, Nephi Stella · 2014 · Inflammopharmacology
30. Metabolites of Cannabigerol Generated by Human Cytochrome P450s Are Bioactive
    Pritam Roy, David G. Dennis, Mark D. Eschbach, Shravanthi D. Anand, Fengyun Xu, Jonathan Maturano, Judith Hellman, David Šarlah, Aditi Das · 2022 · Biochemistry
31. Association of cannabinoid type 1 receptor and fatty acid amide hydrolase genetic polymorphisms in C hinese patients with irritable bowel syndrome
    Yingjie Jiang, Yuqiang Nie, Yuyuan Li, Long Zhang · 2014 · Journal of Gastroenterology and Hepatology
32. Cannabinoid type‐2 receptor agonist, inverse agonist, and anandamide regulation of inflammatory responses in IL‐1β stimulated primary human periodontal ligament fibroblasts
    Ammaar H. Abidi, Sahar S. Alghamdi, Mustafa Kh. Dabbous, David A. Tipton, Suni M. Mustafa, Bob M. Moore · 2020 · Journal of Periodontal Research
33. Repurposing Cannabidiol as a Potential Drug Candidate for Anti-Tumor Therapies
    Fei Wang, Gabriele Multhoff · 2021 · Biomolecules
34. The decrease of dopamine D2/D3 receptor densities in the putamen and nucleus caudatus goes parallel with maintained levels of CB1 cannabinoid receptors in Parkinson's disease: A preliminary autoradiographic study with the selective dopamine D2/D3 antagonist [3H]raclopride and the novel CB1 inverse agonist [125I]SD7015
    Szabolcs Farkas, Katalin Nagy, Zhisheng Jia, Tibor Harkany, Miklós Palkovits, Sean R. Donohou, Victor W. Pike, Christer Halldin, Domokos Máthé, László Csiba et al. · 2012 · Brain Research Bulletin
35. Opioid‐sparing effects of cannabinoids on morphine analgesia: participation of CB 1 and CB 2 receptors
    Xiaohong Chen, Alan Cowan, Saadet Inan, Ellen B. Geller, Joseph J. Meissler, Scott M. Rawls, Ronald J. Tallarida, Christopher S. Tallarida, Mia N. Watson, Martin W. Adler et al. · 2019 · British Journal of Pharmacology
36. Synergistic effects of HIV and marijuana use on functional brain network organization
    Shana A. Hall, Zahra Lalee, Ryan Patrick Bell, Sheri L. Towe, Christina S. Meade · 2020 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
37. Can Cannabidiol Affect the Efficacy of Chemotherapy and Epigenetic Treatments in Cancer?
    Courtney Griffiths, James Aikins, David Philip Warshal, Olga Ostrovsky · 2021 · Biomolecules
38. Host- and Helminth-Derived Endocannabinoids That Have Effects on Host Immunity Are Generated during Infection
    Hashini Batugedara, Donovan Alexander Argueta, Jessica C. Jang, Dihong Lu, Marissa G. Macchietto, Jaspreet Kaur, Shaokui Ge, Adler R. Dillman, Nicholas Vincent DiPatrizio, Meera Goh Nair · 2018 · Infection and Immunity
39. Insights on the antiradical capacity and mechanism of phytocannabinoids: H-abstraction and electron transfer processes in physiological media and the influence of the acid-base equilibrium
    Houssem Boulebd · 2023 · Phytochemistry
40. Cannabinoids inhibit peptidoglycan-induced phosphorylation of NF-κB and cell growth in U87MG human malignant glioma cells
    Ryosuke Echigo, Naotoshi Sugimoto, Akihiro Yachie, Takako Ohno‐Shosaku · 2012 · Oncology Reports
41. Ethanolic extract and water-soluble polysaccharide from Chaenomeles speciosa fruit modulate lipopolysaccharide-induced nitric oxide production in RAW264.7 macrophage cells
    Qing Zhu, Chaolin Liao, Yongmei Liu, Pengcheng Wang, Wei Guo, Meijun He, Zebo Huang · 2012 · Journal of Ethnopharmacology
42. The cannabinoid antagonist SR144528 enhances the acute effect of WIN 55,212-2 on gastrointestinal motility in the rat
    Raquel Abalo, Pablo Antonio Cabezos, Gema Vera, R. Fernández‐pujol, Marı́a Isabel Martı́n · 2010 · Neurogastroenterology & Motility
43. The Endocannabinoid System: An Osteopathic Perspective
    John M. McPartland · 2008 · Journal of Osteopathic Medicine
44. Cannabinoids in the Management of Musculoskeletal Pain
    Kim Madden, Niek van der Hoek, Simrun Chona, Annie George, Tristiana Dalchand, Hassan Baldawi, George Mammen, Mohit Bhandari · 2018 · JBJS Reviews
45. Microglial Endocannabinoid Signalling in AD
    Lucia Scipioni, Francesca Ciaramellano, Veronica Carnicelli, Alessandro Leuti, Anna Rita Lizzi, Noemi De Dominicis, Sergio Oddi, Mauro Maccarrone · 2022 · Cells
46. Headache persisting after aneurysmal subarachnoid hemorrhage: A narrative review of pathophysiology and therapeutic strategies
    Zachary A. Sorrentino, Dimitri Laurent, Jairo S. Hernandez, Caroline Grace Davidson, Coulter N. Small, William Dodd, Brandon Peter Lucke-Wold · 2022 · Headache The Journal of Head and Face Pain
47. Complementary Therapies in Inflammatory Bowel Diseases
    Henit A. Yanai, Nir Salomon, Adi Lahat · 2016 · Current Gastroenterology Reports
48. Suppression of CpG-ODN-mediated IFNα and TNFα response in human plasmacytoid dendritic cells (pDC) by cannabinoid receptor 2 (CB2)-specific agonists
    Joseph E. Henriquez, Robert B. Crawford, Norbert E. Kaminski · 2019 · Toxicology and Applied Pharmacology
49. Imaging Biomarkers of the Neuroimmune System among Substance Use Disorders: A Systematic Review
    Eric A. Woodcock, Ansel T. Hillmer, Graeme F. Mason, Kelly Cosgrove · 2019 · Complex Psychiatry
50. Endocannabinoids and Their Role in Fatty Liver Disease
    Ariane Mallat, Sophie Lotersztajn · 2010 · Digestive Diseases
51. Protective and therapeutic effects of cannabis plant extract on liver cancer induced by dimethylnitrosamine in mice
    Neveen Abd El Moneim Hussein, Mervat El-Toukhy, Amany Hussein Kazem, Mahmoud El-Said Ali, Mohammad Abd El-Rahman Ahmad, Hossam Mahmoud Rashad Ghazy, Ahmed Mohamed Gamal El-Din · 2014 · Alexandria Journal of Medicine
52. New AKT-dependent mechanisms of anti-COVID-19 action of high-CBD Cannabis sativa extracts
    Bo Wang, Dongping Li, Anna Fiselier, Igor Kovalchuk, Olga Kovalchuk · 2022 · Cell Death Discovery
53. Chapter 9 The Endocannabinoid Anandamide
    Fernando Correa, Leyre Mestre, Fabián Docagne, José Ignacio Borrell, Carmen Guaza · 2009 · Vitamins and hormones
54. Palmitoylethanolamide Regulates Development of Intestinal Radiation Injury in a Mast Cell-Dependent Manner
    Junru Wang, Junying Zheng, Ashwini Kulkarni, Wen Wang, Sarita Garg, Paul L. Prather, Martin Hauer‐Jensen · 2014 · Digestive Diseases and Sciences
55. Acute and chronic cannabinoid extracts administration affects motor function in a CREAE model of multiple sclerosis
    Elena Buccellato, Donatella Carretta, Anelì Utan, Chiara Cavina, Ester Speroni, Giampaolo Grassi, Sanzio Candeletti, Patrizia Romualdi · 2010 · Journal of Ethnopharmacology
56. A Metabolomic Approach to the Pathogenesis of Ventilator-induced Lung Injury
    José Luis Izquierdo-García, Shama Naz, Nicolás Nín, Yeny Rojas, Marcela Erazo, Leticia Martínez‐Caro, Antonia Garcı́a, Marta de Paula, Pilar Fernández-Segoviano, Cristina Casals et al. · 2013 · Anesthesiology
57. Acute effects of endocannabinoid anandamide and CB1 receptor antagonist, AM251 in the regulation of thyrotropin secretion
    Marco Aurélio LC Veiga, Flávia Fonseca Bloise, Ricardo Henrique Costa-e-Sousa, Luana L. Souza, Norma Aparecida dos Santos Almeida, Karen Jesus Oliveira, Carmen Cabanelas Pazos-Moura · 2008 · Journal of Endocrinology
58. Anti-inflammatory mechanisms of cannabinoids: an immunometabolic perspective
    Gustav van Niekerk, Tom Mabin, Anna‐Mart Engelbrecht · 2019 · Inflammopharmacology
59. Dermatology-Related Uses of Medical Cannabis Promoted by Dispensaries in Canada, Europe, and the United States
    Megan M. Lim, Mark G. Kirchhof · 2018 · Journal of Cutaneous Medicine and Surgery
60. RETRACTED: The endocannabinoid signaling pathway as an emerging target in pharmacotherapy, earmarking mitigation of destructive events in rheumatoid arthritis
    Ishnoor Kaur, Tapan Behl, SIMONA GABRIELA BUNGAU, Gökhan Zengin, Arun Kumar, Mohamed Ahmed El-Esawi, Gaurav Khullar, Thangavel Venkatachalam, Sandeep Arora · 2020 · Life Sciences · Retracted
61. The Pharmacology of the Cannabinoid System—A Question of Efficacy and Selectivity
    Christopher John Fowler · 2007 · Molecular Neurobiology
62. Inverse agonism of cannabinoid CB1 receptor blocks the adhesion of encephalitogenic T cells in inflamed brain venules by a protein kinase A-dependent mechanism
    Barbara Rossi, Elena Zenaro, Stefano Angiari, Linda Ottoboni, Simona Bach, Laura M. Piccio, Enrica Caterina Pietronigro, Elio Angelo Scarpini, Mariella Fusco, Alberta Leon et al. · 2011 · Journal of Neuroimmunology
63. Cannabinoid use in psychotic patients impacts inflammatory levels and their association with psychosis severity
    Claire L. Gibson, Anahita Bassir Nia, Sharron A. Spriggs, Daniel DeFrancisco, Amy Swift, Charles Perkel, Xiaobo Zhong, Madhu Mazumdar, Nicolas Fernandez, Manishkumar Patel et al. · 2020 · Psychiatry Research
64. Anti‐Inflammatory, Antioxidative, and Hepatoprotective Effects of Trans Δ9‐Tetrahydrocannabinol/Sesame Oil on Adjuvant‐Induced Arthritis in Rats
    Morouj Ismail, Hiba A. Hasan, Youmna El-Orfali, Hanan F. Ismail, Ghada Khawaja · 2018 · Evidence-based Complementary and Alternative Medicine
65. Endocannabinoids in the treatment of gastrointestinal inflammation and symptoms
    Marcella Pesce, Giuseppe Esposito, Giovanni Sarnelli · 2018 · Current Opinion in Pharmacology
66. Targeting airway inflammation in cystic fibrosis
    Oliver J. McElvaney, Patricia Wade, Mark P. Murphy, Emer P. Reeves, Noel Gerard McElvaney · 2019 · Expert Review of Respiratory Medicine
67. Effects of cannabinoid receptor 2 synthetic agonist, AM1241, on bleomycin induced pulmonary fibrosis
    Ali Parlar, Seyfullah Oktay Arslan, Önder Yumrutaş, Ebru Elibol, Alper Yalçın, Fatih Üçkardeş, Hasan Aydın, Muhammed Fatih Doğan, Elif Kayhan Kuştepe, Mehmet Kaya Özer · 2020 · Biotechnic & Histochemistry
68. Differential effects of self-reported lifetime marijuana use on interleukin-1 alpha and tumor necrosis factor in African American adults
    Larry Keen, Arlener D. Turner · 2015 · Journal of Behavioral Medicine
69. Tetrahydroindazole derivatives as potent and peripherally selective cannabinoid-1 (CB1) receptor inverse agonists
    Jay M. Matthews, James J. McNally, Peter J. Connolly, Mingde Xia, Bin Zhu, Shawn C. Black, Cailin Chen, Cuifen Hou, Yin Liang, Yuting Tang et al. · 2016 · Bioorganic & Medicinal Chemistry Letters
70. Retraction: The Dietary Polyphenols trans-Resveratrol and Curcumin Selectively Bind Human CB1 Cannabinoid Receptors with Nanomolar Affinities and Function as Antagonists/Inverse Agonists
    Kathryn A. Seely, Mark S. Levi, Paul L. Prather · 2009 · Journal of Pharmacology and Experimental Therapeutics · Retracted
71. Fatty acid amide hydrolase but not monoacyl glycerol lipase controls cell death induced by the endocannabinoid 2-arachidonoyl glycerol in hepatic cell populations
    Sören Siegmund, A Wojtalla, Monika Schlosser, Andreas Zimmer, Manfred Vincenz Singer · 2013 · Biochemical and Biophysical Research Communications
72. The role of cannabinoid receptors and the endocannabinoid system in mantle cell lymphoma and other non-Hodgkin lymphomas
    Agata Magdalena Wasik, Birger Christensson, Birgitta Sander · 2011 · Seminars in Cancer Biology
73. Substances of abuse and the blood brain barrier: Interactions with physical exercise
    Marta A. Małkiewicz, Andrzej Małecki, Michal J. Toborek, Arkadiusz Szarmach, Paweł Jan Winklewski · 2020 · Neuroscience & Biobehavioral Reviews
74. Therapeutic Potential of Cannabinoids in Counteracting Chemotherapy-induced Adverse Effects: An Exploratory Review
    Sattar Ostadhadi, Mahdieh Rahmatollahi, Ahmad Reza Dehpour, Reza Rahimian · 2014 · Phytotherapy Research
75. Cannabinoid CB2 receptor stimulation attenuates brain edema and neurological deficits in a germinal matrix hemorrhage rat model
    Yihao Tao, Jun Tang, Qianwei Chen, Jing Guo, Lin Li, Liming M Yang, Hua Feng, Gang Zhu, Zhi Chen · 2015 · Brain Research
76. Cannabinoids in Health and Disease
    Rosaria Meccariello, Rosanna Chianese · 2016 · InTech eBooks
77. The monoacylglycerol lipase inhibitor KML29 with gabapentin synergistically produces analgesia in mice
    Molly S. Crowe, Catheryn D. Wilson, Emma Leishman, Paul L. Prather, Heather B. Bradshaw, Matthew L. Banks, Steven G. Kinsey · 2017 · British Journal of Pharmacology
78. Reduced Risk of Alcohol‐Induced Pancreatitis With Cannabis Use
    Adeyinka Adejumo, Olalekan H. Akanbi, Kelechi Lauretta Adejumo, Terence Ndonyi Bukong · 2018 · Alcoholism Clinical and Experimental Research
79. Expression of endocannabinoid system components in human airway epithelial cells: impact of sex and chronic respiratory disease status
    Matthew F. Fantauzzi, Jennifer A. Aguiar, Benjamin J.-M. Tremblay, Michael J. Mansfield, Toyoshi Yanagihara, Abiram Chandiramohan, Spencer D. Revill, Min Hyung Ryu, Chris Carlsten, Kjetil Ask et al. · 2020 · ERJ Open Research
80. Cannabinoid System and Neuroinflammation: Implications for Multiple Sclerosis
    Fernando Correa, Fabián Docagne, Leyre Mestre, Frida Loría, Míriam Hernangómez, José Ignacio Borrell, Carmen Guaza · 2007 · NeuroImmunoModulation
81. Cannabinoid receptors as novel therapeutic targets for the management of non-alcoholic steatohepatitis
    Ariane Mallat, Sophie Lotersztajn · 2008 · Diabetes & Metabolism
82. Structure–Effect Relationships of Novel Semi-Synthetic Cannabinoid Derivatives
    Marcus Rudolf Götz, Juan Antonio Collado, Javier Fernández‐Ruíz, Bernd L. Fiebich, Laura García‐Toscano, María Gómez‐Cañas, Oskar Koch, Andreas Leha, Eduardo Muñóz, Carmen M. Navarrete et al. · 2019 · Frontiers in Pharmacology
83. Use of cannabinoids for the treatment of patients with post-traumatic stress disorder
    Marika L. Forsythe, Andrew J Boileau · 2021 · Journal of Basic and Clinical Physiology and Pharmacology
84. Class A and C GPCR Dimers in Neurodegenerative Diseases
    Irina Sousa Moreira, Ana B. Caniceiro, Beatriz Bueschbell, Anke C. Schiedel · 2022 · Current Neuropharmacology
85. Phytocannabinoids as Potential Multitargeting Neuroprotectants in Alzheimer’s Disease
    Sumit Rathod, Yogeeta O. Agrawal · 2023 · Current Drug Research Reviews
86. Medical Cannabis: A Review from the American Society of Pain and Neuroscience
    Natalie H. Strand, Ryan Steven D'Souza, Jay V. Karri, Hemant Kalia, Jacqueline S. Weisbein, Brian J Kassa, Nasir Hussain, Ahish Chitneni, Ryan R. Budwany, Jonathan Michael Hagedorn et al. · 2023 · Journal of Pain Research
87. Do cannabinoids have a therapeutic role in transplantation?
    Mitzi Nagarkatti, Sadiye Amcaoglu Rieder, Venkatesh L. Hegde, Shunsuke Kanada, Prakash S. Nagarkatti · 2010 · Trends in Pharmacological Sciences
88. Cannabinoid receptor-dependent metabolism of 2-arachidonoylglycerol during aging
    Ana C. Pascual, Virginia L. Gaveglio, Norma Maria Giusto, Susana J. Pasquaré · 2014 · Experimental Gerontology
89. The Dual Effect of Cannabinoid Receptor-1 Deficiency on the Murine Postoperative Ileus
    Yongyu Li, Minghua Cao, Brigitte Goetz, Chunqiu Chen, Ya-jing Feng, Changjie Chen, Michael S. Kasparek, Andrej Sibaev, Martin Storr, Martin Ernst Kreis · 2013 · PLoS ONE
90. Δ9-Tetrahydrocannabinol-induced anti-inflammatory responses in adolescent mice switch to proinflammatory in adulthood
    Sarah Moretti, Mara Castelli, Silvia Franchi, Maria Augusta Raggi, Laura Mercolini, Michele Protti, Lorenzo Somaini, Alberto Emilio Panerai, Paola Sacerdote · 2014 · Journal of Leukocyte Biology
91. Differential effects of endogenous, phyto and synthetic cannabinoids on thrombogenesis and platelet activity
    Eberhard Grambow, Daniel Strüder, Ernst Klar, Burkhard Hinz, Brigitte Vollmar · 2016 · BioFactors
92. Host factors associated with serologic inflammatory markers assessed using multiplex assays
    Heather McKay, Jay H. Bream, Joseph B. Margolick, Otoniel Martı́nez-Maza, John Phair, Charles R. Rinaldo, Alison G. Abraham, Lisa P. Jacobson · 2016 · Cytokine
93. Modulation of Human Peripheral Blood Mononuclear Cell Signaling by Medicinal Cannabinoids
    Wesley K. Utomo, Marjan de Vries, Henri Braat, Marco J. Bruno, Kaushal Parikh, Mónica Comalada, Maikel Petrus Peppelenbosch, Harry van Goor, Gwenny Manel Fuhler · 2017 · Frontiers in Molecular Neuroscience
94. Impaired NFAT and NFκB activation are involved in suppression of CD40 ligand expression by Δ9-tetrahydrocannabinol in human CD4+ T cells
    Thitirat Ngaotepprutaram, Barbara L.F. Kaplan, Norbert E. Kaminski · 2013 · Toxicology and Applied Pharmacology
95. Chapter 17 Regulation of Gene Transcription and Keratinocyte Differentiation by Anandamide
    Nicoletta Pasquariello, Sergio Oddi, Marinella Malaponti, Mauro Maccarrone · 2009 · Vitamins and hormones
96. Role of marijuana components on the regenerative ability of stem cells
    Henry P. Miller, Nicholas De Leo, Jeremy M. Badach, Andrew Boyd Lin, John Williamson, Steven C. Bonawitz, Olga Ostrovsky · 2020 · Cell Biochemistry and Function
97. Cannabinoids and Endocannabinoid System Changes in Intestinal Inflammation and Colorectal Cancer
    Viktoriia Cherkasova, Olga Kovalchuk, Igor Kovalchuk · 2021 · Cancers
98. Safety assessment and redox status in rats after chronic exposure to cannabidiol and cannabigerol
    Hana Holcova Polanska, Kateřina Petrláková, Barbora Papoušková, Michal Hendrych, Amir Samadian, Jan Storch, Petr Babula, Michal Masařík, Jan Vacek · 2023 · Toxicology
99. Endogenous cannabinoid anandamide impairs cell growth and induces apoptosis in chondrocytes
    Rodolfo Gómez, Javier Conde, Morena Scotece, Verónica Alexandra Melo López, Francisca Lago, Juan Jesús Gómez-Reino, Oreste Gualillo · 2014 · Journal of Orthopaedic Research®
100. Self-Assembling Cannabinomimetics: Supramolecular Structures ofN-Alkyl Amides
     Stefan Raduner, William H. Bisson, Ruben A Abagyan, Karl‐Heinz Altmann, Jürg Gertsch · 2007 · Journal of Natural Products